New blood filter could save lives in septic shock

NCT ID NCT05011656

Ongoing Disease control Sponsor: ExThera Medical Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new blood filtering therapy for adults in the ICU with septic shock, a life-threatening condition caused by severe infection. The treatment aims to remove harmful substances from the blood to help patients recover faster. The trial includes 15 participants and focuses on safety and early signs of effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPTIC SHOCK

Contacts and locations

Locations

George Washington University

Washington D.C., District of Columbia, 20037, United States
Good Samaritan Hospital

Corvallis, Oregon, 97330, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States
Methodist Hospital

San Antonio, Texas, 78229, United States
Southeast Georgia Health System, Inc.

Brunswick, Georgia, 31520, United States
Trinity Health Mid Atlantic-SMMC

Langhorne, Pennsylvania, 19047, United States
University of Michigan

Ann Arbor, Michigan, 48109, United States
University of Texas Health Science Center at San Antonio (UT Health San Antonio)

San Antonio, Texas, 78229, United States
University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.